Oxford Biomedica (OXB)

Sector:

Pharma and Biotech

Index:

FTSE 250

504.00p
   
  • Change Today:
    -8.00p
  • 52 Week High: 913.00
  • 52 Week Low: 424.00
  • Currency: UK Pounds
  • Shares Issued: 121.06m
  • Volume: 43,722
  • Market Cap: £610.12m
  • RiskGrade: 125
  • Beta: 0.03

OXB Overview

Oxford Biomedica develops innovative new IP-protected , LentiVector® based therapies, leveraging our internal research expertise and know-how. We select patient-centric product candidates and progress these through proof-of-concept, and into early clinical development, before either seeking third-party funding for full development and commercialisation or to develop further in-house.
Registrars: Capita Registrars

Key Personnel

CEO: Frank Mathias
CFO: Lucinda (Lucy) Crabtree
Chairman: Roch Doliveux
Independent Non-Executive Director: Heather Preston
Independent Non-Executive Director: Namrata P Patel
Senior Independent Director: Dame Kay Davies
Non-Executive Dir: Peter Soelkner, Laurence Espinasse, Colin Bond

Contact Details

Address: Windrush Court, Transport Way, Oxford, United Kingdom, OX4 6LT
Phone: +44 (0) 1865 783 000
Fax: +44 (0) 1865 783 001
Website: http://www.oxb.com/

Listings

Sector: Pharma and Biotech(LSE)
Index: techMARK, FTSE 250, FTSE 350, FTSE All-Share, FTSE techMARK Focus
Overseas Listings: BATSLON:OXBL
ISIN: GB00BDFBVT43

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

OXB Market Data

Currency UK Pounds
Share Price 504.00p
Change Today -8.00p
% Change -1.56 %
52 Week High 913.00
52 Week Low 424.00
Volume 43,722
Shares Issued 121.06m
Market Cap £610.12m
Beta 0.03
RiskGrade 125

OXB Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
45.05% below the market average45.05% below the market average45.05% below the market average45.05% below the market average45.05% below the market average
60% below the sector average60% below the sector average60% below the sector average60% below the sector average60% below the sector average
Price Trend
85.62% above the market average85.62% above the market average85.62% above the market average85.62% above the market average85.62% above the market average
62.79% above the sector average62.79% above the sector average62.79% above the sector average62.79% above the sector average62.79% above the sector average
Income Not Available
Growth
47.31% above the market average47.31% above the market average47.31% above the market average47.31% above the market average47.31% above the market average
42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average

What The Brokers Say

Strong Buy 3
Buy 1
Neutral 4
Sell 0
Strong Sell 0
Total 8
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

OXB Dividends

No dividends found

Trades for 15-Oct-2026

Time Volume / Share Price
11:18 731 @ 501.74p
11:18 1,433 @ 501.74p
11:11 221 @ 502.20p
11:10 0 @ 504.00p
11:03 1,582 @ 502.92p

OXB Key Personnel

Chair Roch Doliveux
CEO Frank Mathias
CFO Lucinda (Lucy) Crabtree

Top of Page